首页 正文

APP下载

揭阳早期治疗白癜风优势(潮州有几家治疗白癜风) (今日更新中)

看点
2025-05-28 01:08:14
去App听语音播报
打开APP
  

揭阳早期治疗白癜风优势-【汕头中科白癜风医院】,汕头中科白癜风医院,普宁中药膏药治疗白癜风,汕尾有名的诊所看白癜风,潮州白癜风治疗有效方法,梅州白癜风治疗哪儿效果快,汕尾皮肤白癜风怎样治疗,普宁哪里可以做白癜风移植

  揭阳早期治疗白癜风优势   

The Stallion Springs, California Police Department is warning the public about a cell phone "spoofing" scam that's going around asking for personal information. The spoofing scam appears to look like a legitimate phone call as the caller ID is displayed as the victim's own cellphone number.A voice recording identifies the call is coming from AT&T, and advises the victim that their cellphone account has been compromised and they may be a victim of fraud. The voice recording then asks for the victim to confirm their personal information, specifically asking for the last four digits of their social security number.AT&T confirmed to Stallion Springs Police that this is a phone scam. Police advise that if you receive calls like this, to not answer them. If you do answer, do not give out your personal information. Hang up and call your phone company asking about the legitimacy of the scam or call police. Report spoofing at www.IC3.gov. 989

  揭阳早期治疗白癜风优势   

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274

  揭阳早期治疗白癜风优势   

The Trump administration is considering a new travel ban to replace its original executive order, which has had its legality questioned and is up for a Supreme Court hearing next month, White House national security adviser H.R. McMaster said Sunday."Well, this is something that we're looking at, is how to protect the American people better, how to ensure that we know who these people are who are moving," McMaster told George Stephanopoulos on ABC's "This Week."This renewed discussion of the travel ban comes after Friday morning's terrorist attack in London, in which 30 passengers on a London Underground train were injured after a bomb went off.In a tweet Friday in response to the attack, President Donald Trump called for a "larger, tougher and more specific" travel ban and also called for shutting down terrorist group's use of the internet for indoctrination and recruitment.McMaster echoed the point Sunday."Because of the strength of these terrorist organizations -- why this is a greater danger than ever -- is, first of all, their ability to communicate, to connect what would otherwise be disconnected cells in other places in the world," he said. "The second part of this is their ability to travel and to move and to move people and money and weapons, oftentimes drugs and other illicit goods, internationally. So part of the strategy must be to interdict these networks, interdict them from how they use information, and communicate, but how they move physically, as well.The Supreme Court is set to hear?oral arguments in the travel ban case early next month.The President's executive order would suspend travel from six Muslim-majority countries (Iran, Libya, Somalia, Sudan, Syria and Yemen) for 90 days while the secretary of homeland security and others submit a report on the results of a worldwide review to identify what additional information will be needed from each country to make sure an individual seeking entrance is not a public-safety threat.Responding to a lawsuits from states challenging the ban, the Supreme Court let much of the ban take effect in late June, meaning the 90-day clock started and will hit on or around September 24.Administration officials have not divulged the specifics of their future plans.At a recent homeland security conference in Washington DC, acting Customs and Border Protection Deputy Commissioner Ronald Vitiello said, "We are in the process of action planning about each of the opportunities that the US government has to interview and/or vet potential inbound travelers."That could include "looking at things like social media, looking at things like smart phones, those kinds of windows, if you will, into people's backgrounds and their activity," he said.The-CNN-Wire 2771

  

The U.S. Postal Service handles around 500 million pieces of mail every day. UPS and FedEx deliver 34 million packages combined.With the number of items being shipped and moved around the country, it’s impossible to closely inspect every single item. So, how do they keep us safe with so many packages? The U.S. Postal Service says they have a specific program called the Dangerous Mail Investigations Program to help get involved when suspicious packages come through a facility.They use X-ray technology and trained employees to recognize suspicious packages, but the daily volume of mail makes it a constant battle.One of the problems with the recent slew of packages delivered is that the packages were missing postmarks. The question is: how did they get missed and still delivered? As the FBI and USPS continue to find out information about what happened, the new attention given to the U.S. Postal Service is under new scrutiny.  959

  

The winds were so strong on July 26 in Redding, California, authorities say they uprooted trees, ripped roofs off houses and downed power lines.The fast-moving Carr Fire took three family members from Ed Bledsoe that day -- his wife and two great-grandchildren."The tornado was hovering over the house," Amanda Woodley, Bledsoe's granddaughter, told CNN. "It was just a tornado fire over the house."Bledsoe had left the house earlier to go to the doctor's office, and was on the phone with his family members as the flames closed in. They believed they were safe from the fire and knew nothing of the approaching hellscape that was like nothing any of them had ever seen before.He said his son drove toward the flames in the hope of rescuing his family members. "My son said the grass wasn't on fire, the trees were getting sucked up in the air and burning," Bledsoe told CNN. "He said when he opened his doors, the leaves hit him like somebody was slapping him. He said it was sucking his breath out, and he got back in his car and tried to get out."Bledsoe was on the phone with his wife and great-grandchildren until the very end."It sucked the roof off the house and the walls fell out and the roof went right down on them," he said.The Carr Fire, now the sixth most destructive fire in California history, has consumed 121,000 acres and killed six people.Dr. Craig Clements of San Jose State University's Fire Weather Research Laboratory said there have been few observed firenadoes of this magnitude before. He says the conditions have to be perfect for something like this to occur.Firenadoes are formed from a fire's intense heat, causing the air to heat up quickly and rise rapidly. That, combined with surface winds that are obviously quite strong, creates a vortex similar to a dust devil.Clements says aside from the potentially damaging winds, a firenado like this can even pull fire in different directions.At 3:27 p.m. that day, the National Weather service sent out a statement noting that "radar indicates strong rotation located within the intense fire activity of the Carr Fire." They warned of possible wind gusts up to 50 mph."The wind went from zero wind to 40 to 60 mph winds within 15 minutes," Justin Sanchez told CNN. He said his house was consumed by the firenado. "(There was) a loud disturbing deep growling noise as it spun around in a spiral. It seemed the outside was moving around so slowly, with two-foot sized pieces of debris floating in it."Sanchez says when he and his family were about a mile and a half from his home, they looked back and could see their neighborhood consumed by it. 2631

来源:资阳报

分享文章到
说说你的看法...
A-
A+
热门新闻

治白癜风梅州哪家最好

汕尾治疗白癜风效果如何

揭阳治疗白癜风真实案例

汕头 白癜风治疗仪 价格

潮州哪里看白癜风再好

汕尾治疗白癜风到哪家较好

梅州慢性白癜风怎么治疗

梅州治疗白癜风专家推荐

汕尾白癜风患者的早期症状

潮州白癜风的治疗费用

汕头什么时候治疗白癜风比较好

汕头哪里可以看白癜风的

潮州白癜风的治疗真的好吗

潮州最好治疗白癜风的办法

普宁白癜风去哪看比较好

汕尾男性白癜风治疗方法

普宁白癜风门诊哪家靠谱

梅州治疗白癜风费用高不

潮州哪家中医治疗白癜风好

普宁在哪里治疗白癜风好

汕尾白癜风治疗一般多少钱

揭阳白癜风检查项目及费用

潮州治疗白癜风的民间中医

潮州专门治疗白癜风的地方

汕头哪个专家能治好白癜风

潮州哪里可以查白癜风